Purgo Labs
$44.99- Price / mg
- $0.45
- Document access
- Public link
Live UPS rate; free UPS 3 Day Select over $250
Six public US 100 mg GHK-Cu listings that keep an unavailable row visible while calculating the headline range from currently available prices only.
Where to buy GHK-Cu 100 mg? Peptide Local does not select a seller or treat these research listings as approved for human use. As of Aug 22, 2026, 5 confirmed in-stock listings run from $44.99 to $65.00, with a $49.00 median across the in-stock rows. All 6 seller pages remain visible below.
Live UPS rate; free UPS 3 Day Select over $250
Free shipping over $175; lower-order rate at checkout
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Live UPS rate; free UPS 3 Day Select over $250
Open vendor evidence profile →Public batch reports. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Purgo Labs row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter GHK-Cu vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked August 22, 2026 at 8:49 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 100 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Purgo LabsLowest in-stock list priceIn stock | $44.99Source confirmed | $0.45 | Public batch reportsAccess: Public link · Seller claim · Aug 22, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
02Pure Health PeptidesPrice and stock confirmed Jul 27In stock | $49.00Source confirmed | $0.49 | Public lot COA libraryAccess: Public link · Seller claim · Aug 22, 2026 | Free shipping over $175; lower-order rate at checkout | |
03Pax PeptidePublic batch-document routeIn stock | $49.00Source confirmed | $0.49 | Public batch COAAccess: Public link · Seller claim · Aug 22, 2026 | Free UPS Ground over $250; lower-order rate at checkout | |
04Onyx BioLabsApproved partner; tracking heldIn stock | $54.99Source confirmed | $0.55 | Public batch-report libraryAccess: Public link · Seller claim · Aug 22, 2026 | $11.99 standard; free over $200 | |
05Prime PeptidesPublic testing routeIn stock | $65.00Source confirmed | $0.65 | Test page linkedAccess: Public link · Seller claim · Aug 22, 2026 | $9.95 US; free over $150 | |
06Pepta LabsHistorical price-change row; unavailableOut of stock | $69.37Source confirmed | $0.69 | COA on requestAccess: On request · Seller claim · Aug 22, 2026 | Free US shipping claimed |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact GHK-Cu 100 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The 100 mg variation was in stock and the page displayed current batch reports dated July 7 and June 5, 2026. Peptide Local did not authenticate custody or contents.
The exact 100 mg variation was purchasable and the product route links to the seller’s public COA library. Peptide Local did not authenticate the batch, custody, or vial contents.
The seller page showed a 100 mg in-stock listing with a public batch-document route. Peptide Local verified the published listing and document access, not chain of custody or contents.
Seller links to its testing area from the product page. Peptide Local records the link and seller claim without treating it as independent verification.
Seller states third-party HPLC purity and ESI-MS identity testing. The 100 mg option was marked out of stock when checked.
The exact 100 mg variation was in stock and linked the seller's public batch-report library, which displayed a current 100 mg GHK-Cu row. Peptide Local recorded the public path without authenticating sample custody or vial contents.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the GHK-Cu 100 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Purgo Labs is $20.01 lower before shipping.
Purgo Labs is $10.00 lower before shipping.
Purgo Labs is $4.01 lower before shipping.
Purgo Labs is $4.01 lower before shipping.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
The public list price moved from $60.99 in Peptide Local's 2026-07-17 snapshot to $67.09 after four matching source checks. That is a $6.10 increase, or 10.00%.
The listing was recorded as out of stock at publication and displayed at price position 6 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete GHK-Cu price history →Open the full peptide price change record →The copper complex and free peptide are not interchangeable labels. This board compares pages that explicitly identify a 100 mg GHK-Cu listing.
Read the PubChem compound record ↗Compare serum, research, injection, and trial categories →Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Aug 22, 2026This record resolves a name to the US laboratory research catalog tracked by Peptide Local. It does not establish authorization, lawful supply, medical use, or availability in the selected destination.
Read the PubChem compound recordNational Library of Medicine, PubChem↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row5 currently confirmed in stock↓GHK-Cu is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search GHK-Cu on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 1 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
Health Canada names GHK-Cu among injectable peptide drugs often sold illegally and records GHK-Cu among unauthorized injectable products seized in Canada. Those records do not authenticate a different listing, seller, presentation, import route, or supply claim.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Aug 22, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $44.99 from Purgo Labs. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
5 confirmed in-stock rows link to a public seller document route: Purgo Labs, Pure Health Peptides, Pax Peptide, Onyx BioLabs, Prime Peptides. The lowest of those rows is Purgo Labs at $44.99. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 100 mg nominal size. The current lowest row states: Live UPS rate; free UPS 3 Day Select over $250. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact GHK-Cu identity and 100 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.